@incollection{, C0BA0A4FCB1DC98F360229B662F98B10 , author={{Dr. Ashfaq ulHassan} and {Dr. ShaziaNazir} and {SKIMS}}, journal={{Global Journal of Medical Research}}, journal={{GJMR}}2249-46180975-588810.34257/GJMR, address={Cambridge, United States}, publisher={Global Journals Organisation}15313 } @incollection{b0, , title={{The metabolic syndrome: Time for a critical appraisal-joint statement from the American Diabetes Association and the European Association for the Study of Diabetes}} , author={{ RKahn }} , journal={{Diabetes Care}} 28 9 , year={2005} } @book{b1, , title={{Will acarbose improve the metabolic abnormalities of insulin-resistant type 2 diabetes mellitus. Diabetes Research and Clinical Practice}} , author={{ RScott }} , year={1999. March} 43 } @incollection{b2, , title={{Animal models of syndrome X. Current Topics in}} , author={{ EShafrir }} , journal={{Diabetes Research}} 12 , year={1993} } @incollection{b3, , title={{The metabolic syndrome as a precursor of cardiovascular disease and type 2 diabetes}} , author={{ PwfWilson } and { D' Agostino } and { RBParise } and { HSullivan } and { LMeigs } and { JB }} , journal={{Circulation}} 112 , year={2005} } @incollection{b4, , title={{The metabolic syndrome: prevalence in worldwide populations}} , author={{ AJCameron } and { JEShaw } and { PZZimmet }} , journal={{Endocrinol Metab Clin N Am}} 33 , year={2004} } @incollection{b5, , title={{The atherogenic lipoprotein profile associated with obesity and insulin resistance is largely attributable to intraabdominal fat}} , author={{ DJNieves } and { MCnop } and { BRetzlaff }} , journal={{Diabetes}} 52 , year={2003} } @incollection{b6, , title={{Abdominal obesity, muscle composition, and insulin resistance in premenopausal women}} , author={{ RRoss } and { JFreeman } and { RHudson } and { IJanssen }} , journal={{J Clin Endocrinol Metab}} 87 , year={2002} } @incollection{b7, , title={{Clinical review 115: effect of thyroxin therapy on serum lipoproteins in patients with mild thyroid failure: a quantitative review of the literature}} , author={{ MDDanese } and { PWLadenson } and { CLMeinert } and { NRPowe }} , journal={{J Clin Endocrinol Metab}} 85 , year={2000} } @incollection{b8, , title={{The insluin resistance syndrome: impact on lipoprotein metabolism and atherothrombosis}} , author={{ HNGinsberg } and { LSHaung }} , journal={{J Cardiovasc Risk}} 7 , year={2000} } @incollection{b9, , title={{cloning and sequencing of the human cholesteryl ester transfer protein cDNA}} , author={{ DDrayna } and { ASJamagin } and { JMclean }} , journal={{Nature}} 327 6324 , year={1987} } @incollection{b10, , title={{Cholesteryl ester transfer protein and its plasma regulator: lipid transfer inhibitor protein}} , author={{ REMorton }} , journal={{Curr Opin Lipidol}} 10 , year={1999} } @incollection{b11, , title={{Increased plasma cholesteryl ester transfer protein in obese subjects: a possible mechanism for the reduction of serum HDL cholesterol levels in obesity}} , author={{ TArai } and { SYamashita } and { KHirano }} , journal={{Arterioscler Thromb}} 14 , year={1994} } @incollection{b12, , title={{The metabolic syndrome; more than the sum of its parts}} , author={{ MPReilly } and { DJRader }} , journal={{Circulation}} 108 , year={2003} } @incollection{b13, , title={{The metabolic syndrome: practical guide to origins and treatment: part I}} , author={{ PWWilson } and { SMGrundy }} , journal={{Circulation}} 108 , year={2003} } @incollection{b14, , title={{High density lipoproteins and coronary heart disease}} , author={{ PJBarter } and { KARye }} , journal={{Atherosclerosis}} 121 , year={16996} } @incollection{b15, , title={{Clustering of metabolic factors and coronary heart disease}} , author={{ PWWilson } and { WBKannel } and { HSilbershatz }} , journal={{Arch Intern Med}} 159 , year={1999} } @incollection{b16, , title={{Resistance to insulin-mediated glucose disposal as a predictor of cardiovascular disease}} , author={{ JYip } and { GMFacchini Fs Reaven }} , journal={{J Clin Endocrinol Metab}} 83 , year={1998} }